Advertisement

Topics

STAT Plus: NGM Biopharmaceuticals wants to be the next billion-dollar biotech on Wall Street, and so it's moving forward with an IPO that offers a springtime referendum on investor sentiment. https://buff.ly/2HU5cmC 

10:00 EDT 26 Mar 2019 | STAT

STAT Plus: NGM Biopharmaceuticals wants to be the next billion-dollar biotech on Wall Street, and so it's moving forward with an IPO that offers a springtime referendum on investor sentiment. https://buff.ly/2HU5cmC 

Original Article: STAT Plus: NGM Biopharmaceuticals wants to be the next billion-dollar biotech on Wall Street, and so it's moving forward with an IPO that offers a springtime referendum on investor sentiment. https://buff.ly/2HU5cmC 

NEXT ARTICLE

More From BioPortfolio on "STAT Plus: NGM Biopharmaceuticals wants to be the next billion-dollar biotech on Wall Street, and so it's moving forward with an IPO that offers a springtime referendum on investor sentiment. https://buff.ly/2HU5cmC "

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology Products
BioPortfolio lists over 550 biotechnology products - please open http://www.bioportfolio.com/channels?category_id=5 Direct topic pages: Actos Advair Biopharmaceuticals Biosimilars Biotherapeutics GMO Crops Lipitor ...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...